Gene Therapy Program for ALS Due to C9orf72 Mutations Opening in UK

Gene Therapy Program for ALS Due to C9orf72 Mutations Opening in UK

308067

Gene Therapy Program for ALS Due to C9orf72 Mutations Opening in UK

Research into gene therapies for motor neuron diseases (MNDs), a group of progressive neurological disorders that includes amyotrophic lateral sclerosis, is set to begin at the University of Sheffield in collaboration with Cell and Gene Therapy Catapult. Supported by a £513,141 (about $700,00) grant from LifeArc and the MND Association, both also based in the U.K., the program will assess the feasibility and efficiency of gene therapies for MND and frontotemporal dementia (FTD) patients carrying mutations…

You must be logged in to read/download the full post.